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Letters to the Editorentity. There are 4.6 million people in the
United States with heart failure today, and
550,000 new cases are being reported an-
nually by the American Heart Associa-
tion.5 Approximately 30% to 50% of pa-
tients with heart failure have a normal or
nearly normal left ventricular ejection frac-
tion.6 CHF is a leading cause of cardiac
morbidity and mortality from cardiovascu-
lar disease. Although left ventricular dia-
stolic dysfunction occurs in all patients
with systolic dysfunction and CHF, a third
of patients have CHF with isolated dia-
stolic dysfunction. In the general popula-
tion, the mortality among patients with di-
astolic heart failure is 4 times that among
persons without heart failure but half that
among patients with systolic heart failure.
It is widely known that many physicians
underappreciate diastolic function in heart
failure.
Reinterpreting the data in the context of
the discussion asks for other explanations.
In the present era of advancements in echo-
cardiography, diastolic dysfunction needs
to be taken into consideration, especially
when symptoms of congestive heart failure
are present. If that is the case in this study,
left ventricular dysfunction remains a pre-
dictor of outcome but with a change from
systolic to diastolic. Finally, I ask Davier-
wala and colleagues to take a second look
at their data in the light of this forgotten
predictor variable. I would appreciate their
feedback.
Jeffrey H. Shuhaiber, MD
University of Illinois at Chicago
Chicago, IL 60612
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Reply to the Editor:
Dr Shuhaiber correctly points out that left
ventricular (LV) diastolic dysfunction is
frequently superimposed on either normal
or reduced systolic function in patients un-
dergoing coronary artery bypass grafting.
The importance of diastolic dysfunction in
the development and progression of con-
gestive heart failure (CHF) has been illus-
trated previously1 and is highlighted by the
divergent trends in the prevalence of LV
systolic dysfunction and CHF in the series
on which we reported. Early echocardio-
graphic signs of impaired LV relaxation
include decreased early transmitral LV fill-
ing and greater dependence on atrial con-
traction.2 Pseudonormalization of LV fill-
ing is observed as LV stiffness and left
atrial pressures continue to increase, and
finally severe diastolic dysfunction is
marked by rapid early filling, extreme LV
stiffness, and elevated diastolic pressures.
This diastolic dysfunction has been shown
to predict outcomes in patients with CHF
independently of systolic function.3
Despite this, echocardiographic charac-
terization and quantitation of LV diastolic
dysfunction is not performed and recorded
for all patients undergoing coronary sur-
gery. This may be due in part to logistical
issues and in part to underappreciation of
its prognostic significance. Like systolic
function, diastolic function may also vary
significantly with time in patients with in-
termittent ischemia or a maturing myocar-
dial infarction.
Our institutional database, initiated in
1982 and now encompassing approxi-
mately 40,000 surgical patients, does not as
yet contain uniform data on diastolic func-
tion, nor does the much larger Society of
Thoracic Surgeons database. Thus, al-
though one may reasonably speculate that
the prevalence of diastolic dysfunction in
patients undergoing coronary artery bypass
grafting is increasing in parallel with other
risk factors, as we have reported in this
series, our data do not currently permit
evaluation of the independent effect of di-
astolic function on mortality and morbid-
ity. These measures of diastolic dysfunc-
e Journal of Thoracic and Cardiovascular Stion will have to obtained routinely for all
patients undergoing surgery and incorpo-
rated into institutional and regional data-
bases before we be able to determine
whether the decreasing influence of LV
systolic dysfunction on outcomes has un-
masked relatively more subtle predictors,
including CHF and left main stenosis as we
have reported or diastolic dysfunction as
Dr Shuhaiber suggests.
Piroze M. Davierwala, MD
Terrence M. Yau, MD, MSc
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Extracapsular lymph node
involvement in esophageal cancer
and number of involved nodes
To the Editor:
We thank Dr DeMeester1 for his valuable
comments on our article “Extracapsular
Lymph Node Involvement Is a Negative
Prognostic Factor in T3 Adenocarcinoma
of the Distal Esophagus and Gastroesoph-
ageal Junction.”2 We fully agree with Dr
DeMeester1 that the number and character-
istics of lymph nodes are very important
determinants of survival in esophageal can-
cer, and we endorse his plea for taking the
number of involved nodes into account in
the TNM staging system of esophageal
cancer.
In his editorial,1 Dr DeMeester made
some points that we would like to clarify.
With regard to the survival in patients with-
out nodal involvement versus patients with
intracapsular nodal involvement, there was
no significant difference in survival. This
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